
Adience Pharma Private Limited
About Adience Pharma Private Limited
Data last updated:
Adience Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 27 February 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24110DL2007PTC159817. Its GSTIN is 07AAACZ2893F1Z4 (Delhi).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹4.5 Lakh. It was formerly known as Zlb Pharma Private Limited. It is led by directors Anil Sawhney and Rishabh Sawhney.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B 24 (Basement) Suneja Towers 1 District Centre Janak Puri, New Delhi, Delhi, India – 110058.
As per the financials filed for FY 2025, the company reported a revenue of ₹11.8 Cr. For the same year it recorded a net profit of ₹11.05 Lakh (net margin 0.9%) and EBITDA of ₹16.53 Lakh (EBITDA margin 1.4%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 7% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Adience Pharma Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressB 24 (Basement) Suneja Towers 1 District Centre Janak Puri, New Delhi, Delhi, India – 110058
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Adience Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Adience Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Adience Pharma Private Limited, buy the company report.
Financials of Adience Pharma Private Limited
FY 2025 filings availableAdience Pharma Private Limited reported revenue of ₹11.8 Cr for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 7% over five years. EBITDA rose 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹16.53 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹11.05 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.4% | ||||
| Net Profit Margin | 0.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Adience Pharma Private Limited, buy the company report.
Board of directors of Adience Pharma Private Limited
Adience Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anil Sawhney | Director | 27 Feb 2007 | 19 Years 8 Months | Current |
| Rishabh Sawhney | Director | 29 Aug 2023 | 3 Years 2 Months | Current |
Peer comparison
Adience Pharma Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Naiom Healthcare Private Limited | ₹11.92 Cr (FY 2024) | 4.0% | Jalgaon, Maharashtra, India | |||
| Resonance Healthcare India Private Limited | ₹11.91 Cr (FY 2017) | -19.0% | New Delhi, Delhi, India | |||
| Veenags Healthcare Private Limited | ₹11.91 Cr (FY 2023) | 5.0% | New Delhi, Delhi, India | |||
| Adience Pharma Private Limitedthis company | ₹11.8 Cr (FY 2025) | ₹11.05 Lakh | 0.9% | New Delhi, Delhi, India | ||
| Noble Wellness Private Limited | ₹11.75 Cr (FY 2025) | 32.0% | New Delhi, Delhi, India |
To see the full peer comparison of Adience Pharma Private Limited, buy the company report.
Auditor
Adience Pharma Private Limited is audited by MANISH MOHAN AGRAWAL & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MANISH MOHAN AGRAWAL & CO | FY 2019 | 022451N |
Shareholding
The shareholding of Adience Pharma Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Adience Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Adience Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Adience Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Adience Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACZ2893F1Z4 | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Adience Pharma Private Limited, buy the company report.
Recent activity
Adience Pharma Private Limited has 4 board changes on record since 2007: 2 appointments and 2 cessations. The latest: Neeru Sawhney ceased to be Director on 06 Apr 2024.
Frequently asked questions
Adience Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 27 February 2007 (19+ years old) and is registered under CIN U24110DL2007PTC159817.
Adience Pharma has 2 current directors:
- Anil Sawhney - Director
- Rishabh Sawhney - Director
The latest financial statements of Adience Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Adience Pharma is 07AAACZ2893F1Z4, registered in Delhi.
The CIN (Corporate Identification Number) of Adience Pharma is U24110DL2007PTC159817. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Adience Pharma was incorporated on 27 February 2007, making it 19+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Adience Pharma by revenue are Naiom Healthcare Private Limited, Resonance Healthcare India Private Limited, Veenags Healthcare Private Limited, Noble Wellness Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Neeru Sawhney ceased to be Director on 06 Apr 2024. Rishabh Sawhney ceased to be Additional Director on 29 Sep 2023. Rishabh Sawhney was appointed as Director on 29 Aug 2023. Adience Pharma has 4 board changes on record in total.
The registered office of Adience Pharma is at B 24 Basement Suneja Towers 1 District Centre Janak Puri, New Delhi, Delhi, India – 110058.
Adience Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Adience Pharma is compliant as of 18 July 2026. The company is actively filing with the Registrar of Companies.

